RNA Interference: Big Applause for Silencing in Stockholm  by Zamore, Phillip D.
Leading Edge
EssayRNA Interference: Big Applause for 
Silencing in Stockholm
Phillip D. Zamore1,*
1Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA 01605, USA
*Contact: phillip.zamore@umassmed.edu
DOI 10.1016/j.cell.2006.12.001
Eight years ago, Craig Mello, Andrew Fire, and their coworkers provided the first demon-
stration that double-stranded RNA (dsRNA) triggers the gene-silencing technique that we 
now call RNA interference (RNAi). For this landmark discovery, Mello and Fire are honored 
with this year’s Nobel Prize in Physiology or Medicine.If fields of study have birthdays, then 
RNA interference (RNAi) turned eight 
on February 19th this year. Even by 
the standards of 21st century science, 
RNAi has been precocious. A PubMed 
search for “RNA interference” retrieves 
more than 7900 articles, all published 
after the landmark 1998 Nature paper 
by Craig Mello at the University of 
Massachusetts Medical School and 
Andy Fire, then at the Carnegie Insti-
tution and now at Stanford University 
School of Medicine, that launched the 
whole field (Fire et al., 1998; see Fig-
ure 1). In this paper, Mello, Fire, and 
their colleagues working in the worm 
Caenorhabditis elegans provided the 
first demonstration that RNA interfer-
ence (RNAi), as the new gene-silenc-
ing technique had just been named, 
is triggered by double-stranded RNA 
(dsRNA). For this discovery they are 
honored with this year’s Nobel Prize in 
Physiology or Medicine.
The Fire and Mello discovery 
proved that RNAi is mechanistically 
distinct from antisense RNA-based 
strategies for inhibiting gene expres-
sion. More fundamentally, their 1998 
paper, often referred to simply as the 
Fire and Mello paper, suggested that 
dsRNA—presumed by most biologists 
either to be inert or, to those studying 
mammals, to signal the presence of 
a viral infection—could repress the 
expression of a single gene. Such 
a role for RNA harked back to ideas 
from the 1960s that small pieces of 
RNA might bind to genes, turning 
them off, ideas abandoned after the 
discovery of transcription factors.Defining RNAi, Creating a New 
Field
Rereading the 1998 paper, one is 
struck by how many of the salient fea-
tures of RNAi were identified by Fire 
and Mello: the ability of a few mol-
ecules of dsRNA to direct destruc-
tion of a much larger amount of the 
corresponding mRNA, suggesting a 
catalytic mechanism; the transmis-
sion of RNAi across generations; 
the power of RNAi to bring genet-
ics to any organism whose genome 
sequence is known; the near univer-
sality of RNAi among eukaryotes. Fire 
and Mello transformed into testable Cell 127, Decemscience a “phenomenon”—a word 
scientists often use to imply that the 
observation might yet prove untrue. 
Many of us read their paper or heard 
Craig Mello speak about it at meet-
ings and immediately changed direc-
tion. I was a bit late in discovering 
the paper, reading it only in March 
1999; by May, RNAi was my consum-
ing passion. Others in the field have 
similar stories; quite a few can tell you 
where they were the first time they 
heard of RNAi.
Great papers give rise to whole 
fields when they not only report 
a discovery but also pose a chal-Figure 1. A Young Field Sweeps the Nobel Prize
Craig Mello (left) and Andrew Fire (right) have been awarded this year’s Nobel prize in Physiology 
or Medicine for their discovery of the gene-silencing technique called RNA interference. Photos 
courtesy of Robert Carlin/UMass Medical School (left) and L.A. Cicero/Stanford University News 
Service (right).ber 15, 2006 ©2006 Elsevier Inc. 1083
lenge to the scientific community. 
Fire and Mello dared us to imagine 
that the technique of RNAi—which 
they taught was the introduction of 
dsRNA into the nematode C. elegans 
for the purpose of interfering with the 
expression of a single gene—was a 
clue to a wholly new regulatory mech-
anism. “The mechanisms underlying 
RNA interference,” they wrote in their 
landmark paper, “probably exist for a 
biological purpose” (Fire et al., 1998). 
The challenge to find that biology and 
explain both how it worked and why 
it existed was irresistible. RNAi was 
not just useful technology, it was biol-
ogy—unexplored, understandable-if-
only-we-think-hard-enough biology.
RNAi occurs when cells respond to 
a dsRNA trigger by destroying a cor-
responding target, an mRNA sharing 
some or all of the sequence of the 
dsRNA. RNAi, we now understand, is 
but one of a group of mechanistically 
related RNA-silencing phenomena, 
all of which have in common small 
RNAs, often derived from longer 
dsRNA precursors, that guide protein 
complexes to target genes or mRNA, 
whose expression they silence. 
Besides RNAi, RNA-silencing path-
ways include the microRNA (miRNA) 
pathways of plants and animals, in 
which small RNAs derived from their 
own genes repress tens or hundreds 
of target mRNAs to which they are par-
tially complementary. Small RNAs can 
also guide modification of chromatin 
structure, promoting the assembly 
of heterochromatin. In the protozoan 
Tetrahymena, such an RNA-silencing 
pathway uses small RNAs to mark 
specific DNA sequences for deletion 
from the macronuclear genome. RNA 
silencing also includes the rasiRNA 
and piRNA pathways, the first small 
RNA pathways for which there are no 
known dsRNA precursors contribut-
ing to the production of small RNAs.
Early Observations of Silencing
Hints of the existence of RNA-silenc-
ing pathways first came from experi-
ments in plants. Rich Jorgensen and 
colleagues engineered petunias car-
rying transgenic copies of the gene 
encoding chalcone synthase, the lim-
iting enzyme in the synthesis of the 1084 Cell 127, December 15, 2006 ©200flower’s purple pigment. Their intent 
was to generate more intensely purple 
flowers, but often their efforts yielded 
plants with dramatic pigmentation 
patterns comprising tissue in which 
chalcone synthase was produced, 
flanking tissue in which both the 
transgenic and endogenous chalcone 
synthase genes were mysteriously 
turned off. They dubbed this phe-
nomenon “cosuppression” (Napoli et 
al., 1990; van der Krol et al., 1990). 
Jim Birchler, working in Drosophila 
melanogaster, similarly reported that 
the more transgenic copies of alcohol 
dehydrogenase (adh) that were engi-
neered into flies, the less adh mRNA 
was actually made.
In the mid-1990s, David Baul-
combe’s laboratory discovered 
that plant viruses could also trigger 
sequence-specific silencing. More-
over, they showed that this virus-
induced gene silencing (VIGS) was 
mechanistically related to the silenc-
ing triggered by transgenes; the link 
between the two silencing pathways 
was that both required transcription 
of RNA from the trigger locus, impli-
cating RNA as the initiator of silencing 
(Ratcliff et al., 1997). More recently, 
viral defense has been proposed 
to be the primary function of RNAi 
in both plants and flies. Presciently, 
Baulcombe suggested that dsRNA—
formed by two RNA molecules 
annealing or one folding back on 
itself—might be recognized by plant 
cells as a trigger for the sequence-
specific silencing of genes (Ratcliff 
et al., 1997). Nine months later, Fire 
and Mello proved this to be true for 
RNAi in animals, and Waterhouse and 
colleagues subsequently showed the 
same for plants.
In animals, the application of 
antisense technology to inhibit gene 
expression in the worm C. elegans 
led to the discovery of RNAi. The 
rationale was that injection of anti-
sense RNA corresponding to a 
cellular mRNA should block trans-
lation of that mRNA through base-
pairing, converting the mRNA to 
an untranslatable and presumably 
inert form. Ken Kemphues’ labora-
tory, however, found that injection 
of the mRNA itself (sense RNA) also 6 Elsevier Inc.“interfered” with its own expres-
sion, an observation at odds with 
an antisense mechanism (Guo and 
Kemphues, 1995). It was in this 
context—a series of paradoxical 
and intriguing reports that an exog-
enously provided RNA could inter-
fere with expression of an identi-
cal endogenous mRNA—that Fire 
and Mello formulated their unifying 
hypothesis: eukaryotic cells per-
ceive dsRNA as a sequence-spe-
cific signal to inhibit expression of 
the corresponding mRNA. Their 
idea resolved the paradox inher-
ent in the experiments of Guo and 
Kemphues and provided a testable 
model for the mechanism of RNAi in 
particular and RNA-silencing phe-
nomena in general.
With their 1998 paper, Fire and 
Mello inspired others to find RNAi 
in their favorite organism or to study 
it using their favorite techniques. 
By December of that year, Richard 
Carthew’s laboratory had shown 
that dsRNA triggered a robust RNAi 
response in fly embryos (Kennerdell 
and Carthew, 1998), a finding that 
led directly to the development of the 
first in vitro system for recapitulating 
RNAi in a cell extract (of Drosophila 
embryos) (Tuschl et al., 1999). Within 
five years, aspects of RNA silenc-
ing could be studied in vitro for flies, 
mammals, and plants.
Eureka! Small RNAs
The second great breakthrough, 
however, came in October 1999, from 
studies begun before the discovery 
that dsRNA triggered RNAi in ani-
mals. Baulcombe and his student, 
Andrew Hamilton, reported that in 
plants in which a specific gene was 
silenced, there was always accumu-
lation of antisense RNAs ?25 nucle-
otides long that were complementary 
to the silenced gene (Hamilton and 
Baulcombe, 1999). We now call these 
molecules small interfering RNAs 
(siRNAs). The discovery of siRNAs 
ultimately allowed the application of 
RNAi to mammals, but their imme-
diate impact was to elucidate the 
mechanisms underlying both RNAi 
and the related miRNA pathway. In 
vitro experiments in extracts from 
fly embryos and cultured cells soon 
demonstrated that siRNAs are pro-
duced by endonucleolytic process-
ing of the dsRNA trigger by an 
enzyme called Dicer (Bernstein et al., 
2001). MicroRNAs, too, were found to 
be produced by Dicer from double-
stranded stem-loop structures within 
a single transcript, rather than from 
long dsRNA molecules (Bernstein et 
al., 2001; Grishok et al., 2001; Hut-
vágner et al., 2001). The first miRNA, 
lin-4, had been discovered by Victor 
Ambros and coworkers in 1993 (Lee 
et al., 1993); the second, let-7, by Gary 
Ruvkun and coworkers in 2000 (Rein-
hart et al., 2000). (Both lin-4 and let-
7 were identified first in C. elegans.) 
Today, thousands of miRNAs have 
been identified in plants and animals, 
including at least 474 in humans. 
The discovery that both siRNAs and 
miRNAs were produced by the same 
enzyme reinforced the view that RNAi 
existed for a biological purpose.
Small interfering RNAs and 
miRNAs are ?22 nucleotide-long 
RNAs that act as guides—what 
Baulcombe called the “specificity 
determinant”—for Argonautes, a 
diverse family of proteins special-
ized for silencing gene expression. 
Argonaute proteins were first impli-
cated in RNAi when Mello, Fire, and 
coworkers identified the RNAi-defi-
cient 1 (rde-1) gene in a large-scale 
genetic screen for proteins required 
for RNAi in C. elegans (Tabara et 
al., 1999). Worms lacking rde-1 
function cannot mount an RNAi 
response when exposed to dsRNA. 
The sequence of rde-1 revealed 
homologs in nearly every eukary-
ote, from fungi such as Neurospora 
crassa and Schizosaccharomyces 
pombe to plants, flies, and mam-
mals. Although rde-1 mutant worms 
do not support RNAi, they appear 
to be otherwise normal. In contrast, 
plants with mutations in the RDE-1 
homolog, ARGONAUTE-1 (AGO-1), 
identified in Arabidopsis thaliana in 
a genetic screen, develop spike-like 
leaves instead of flat blades with 
distinct top and bottom surfaces. 
We now know that plant AGO-1 
binds to miRNAs, whose function 
is required to specify the distinct developmental fates of the cells that 
form the top and bottom of a leaf. 
The Drosophila RDE-1 homolog, 
Piwi, is required for the maintenance 
of germline stem cells. The Piwi 
protein binds to repeat-associated 
siRNAs (rasiRNAs)—small RNAs 
corresponding to transposons and 
other selfish genetic elements—that 
block expression of RNA from these 
molecular parasites. The discovery 
that RDE-1 defines a large clade of 
related proteins immediately sug-
gested that RNAi-like mechanisms 
play vital roles in regulating gene 
expression in both plants and ani-
mals. The last five years have seen 
an avalanche of data reinforcing this 
view.
In C. elegans, RNAi initiated by 
exogenously supplied dsRNA can 
spread from cell to cell. In fact, RNAi 
can be inherited in worms, the silent 
state of a gene transmitted from 
mother to child. Silencing in plants 
can also spread cell-to-cell, with 
silent root stock triggering silencing 
of the same gene in the uppermost 
leaves of a previously nonsilenced 
graft. Such spreading reflects the 
transport of dsRNA into cells, its 
amplification by RNA-dependent RNA 
polymerases, and the export of some 
form of dsRNA, perhaps siRNAs, 
from the first cell to a second. Sadly, 
this remarkable and bizarre aspect 
of RNAi, recognized in the 1998 Fire 
and Mello paper, has not yet been 
observed in flies or mammals.
Technology, Too
Of course, one cannot overstate the 
importance of RNAi as a tool. Even 
the most hardcore biochemists now 
practice genetics of a sort using 
RNAi.
RNAi-based whole-genome screens 
have become routine for C. elegans 
and cultured Drosophila cells and 
are becoming routine for cultured 
mammalian cells. Thanks to RNAi, 
the effect on a molecular pathway, 
cellular morphology, or organismal 
phenotype of the loss of function 
of every known gene can be deter-
mined in a matter of weeks. Beyond 
the original insight that dsRNA is a 
potent and specific trigger of RNAi, Cell 127, Decemtechnological breakthroughs make 
possible such high-throughput RNAi 
screens. In C. elegans, Fire and Mello 
and their coworkers showed that 
soaking worms in dsRNA, or better 
yet feeding them bacteria expressing 
dsRNA, triggers RNAi. For flies, Jack 
Dixon showed that cultured S2 cells 
spontaneously internalize dsRNA 
from the culture medium, leading to 
a sequence-specific RNAi response. 
More spectacular still was the dis-
covery by Thomas Tuschl and col-
leagues that siRNAs could be chemi-
cally synthesized and administered 
to cultured mammalian cells, eliciting 
a sequence-specific RNAi response 
lasting days and bypassing the non-
sequence-specific responses mam-
malian cells mount when exposed to 
longer dsRNA (Elbashir et al., 2001).
The adaptation of RNAi technology 
to mammals has also inspired the 
hope that RNAi triggered by siRNAs 
might form the basis for new drugs 
capable of silencing viral or human 
genes that cause disease. Both 
young biotechnology companies and 
old pharmaceutical firms are actively 
pursuing this idea. In mice and mon-
keys, intravenous injection of chemi-
cally modified siRNAs can elicit long-
lasting, sequence-specific silencing 
of the corresponding mRNA in sev-
eral different tissues, and the initial 
results from human trials have been 
encouraging that siRNAs are well tol-
erated in people.
What began as the desire of Fire 
and Mello to explain an antisense 
experiment that worked too well pro-
duced a revolutionary insight that has 
forever changed modern biology. Like 
the discovery of the structure of DNA, 
the realization that cells respond to 
dsRNA by silencing the correspond-
ing gene has changed our view of 
gene regulation and the organization 
of DNA into chromosomes. Like the 
invention of PCR, the discovery of 
RNAi provided a transformative new 
technology that brings the power of 
genetics to the bewildering riches 
of genome sequences. And like the 
invention of the CAT scan and MRI 
before it, RNAi promises to transform 
modern medicine. Craig and Andy: 
thank you!ber 15, 2006 ©2006 Elsevier Inc. 1085
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